Emergency Guidelines for the Campus Community
Last update: October 13, 2014
Nine cases of serogroup B meningococcal disease have been associated with Princeton University. The US Centers for Disease Control and Prevention (CDC) and the New Jersey Department of Health are not recommending cancelling or curtailing events or activities on campus.
Meningitis B Vaccine Clinics
The CDC recommends that all Princeton University undergraduate students and eligible graduate students (see eligibility requirements) and and members of the University community with specific medical conditions, including problems with their spleen (including sickle cell disease) or complement pathway (a specific type of immune deficiency)receive a vaccine that helps protect against meningococcal disease caused by serogroup B bacteria. Between March 2013 and March 2014, nine cases of serogroup B meningococcal disease have been associated with Princeton University. There have been no cases occurring on campus or affecting Princeton students since November 2013.
The vaccine is provided in two doses at separate times.
All eligible students may receive the first or second dose Thursday and Friday, Oct. 16-17, noon to 7 p.m. in Frist Campus Center, Level B in the Multipurpose Room.
These clinics are also likely the last chance to get the first dose for those who have not received it yet. Eligible students who have not received the first dose may also do so on these dates, and will have an opportunity to receive the second dose at a later time.
Princeton University will cover the cost of the vaccine. The vaccine will only be available at these clinics, and it will not be administered anywhere else.
Students under the age of 18 will need a signed consent form from their parent or guardian before receiving the vaccine.
Because protection provided by the first dose declines over time, two doses of the vaccine are needed for full immunity.
Meningitis B is not covered by the vaccine that is required for teenagers in the US. There is no vaccine for meningitis B licensed in the US; however, beginning in December 2013, the US Food and Drug Administration (FDA) and the US Centers for Disease Control and Prevention (CDC) allowed the University to import a meningitis B vaccine that is licensed in Europe, Australia and Canada, but not in the US.
Students can help prevent the spread of bacterial meningitis by doing the following:
Students who have received the meningitis B vaccine on campus have likely protected themselves from getting sick, but they can still spread the meningitis bacteria to others who have not been vaccinated.
If you or a close contact becomes sick:
The vaccine will continue to be available for all Princeton University graduate students living in undergraduate dormitories, the Graduate College and annexes, and members of the University community with specific medical conditions, including problems with their spleen (including sickle cell disease) or complement pathway (a specific type of immune deficiency).
For frequently asked questions about the University vaccine clinics, including specific questions about eligible populations, the second dose and more, please visit: http://web.princeton.edu/sites/emergency/meningitis.html.
For frequently asked questions about the vaccine and bacterial meningitis, please visit the CDC's meningitis information website: http://www.cdc.gov/meningococcal/outbreaks/vaccine-serogroupB.html
You may also email the CDC at firstname.lastname@example.org, which is dedicated to answering questions about the vaccine.
This website provides information resources for meningitis. This list of questions and answers and resources on this page will be updated regularly.